The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
Open accessAbstract
Background: Myocardial utilization of 3-hydroxybutyrate (3-OHB) is increased in patients with heart failure and reduced ejection fraction (HFrEF). However, the cardiovascular effects of increased circulating plasma-3-OHB levels in these patients are unknown. Consequently, the authors’ aim was to modulate circulating 3-OHB levels in HFrEF patients and evaluate: (1) changes in cardiac output (CO); (2) a potential dose-response relationship between 3-OHB levels and CO; (3) the impact on myocardial external energy efficiency (MEE) and oxygen consumption (MVO 2 ); and (4) whether the cardiovascular response differed between HFrEF patients and age-matched volunteers. Methods: Study 1: 16 chronic HFrEF patients (left ventricular ejection fraction: 37±3%) were randomized in a crossover design to 3-hour of 3-OHB or placebo infusion. Patients were monitored invasively with a Swan-Ganz catheter and with echocardiography. Study 2: In a dose-response study, 8 HFrEF patients were examined at increasing 3-OHB infusion rates. Study 3 to 4: 10 HFrEF patients and 10 age-matched volunteers were randomized in a crossover design to 3-hour 3-OHB or placebo infusion. MEE and MVO 2 were evaluated using 11C-acetate positron emission tomography. Results: 3-OHB infusion increased circulating levels of plasma 3-OHB from 0.4±0.3 to 3.3±0.4 mM ( P <0.001). CO rose by 2.0±0.2 L/min ( P <0.001) because of an increase in stroke volume of 20±2 mL ( P <0.001) and heart rate of 7±2 beats per minute (bpm) ( P <0.001). Left ventricular ejection fraction increased 8±1% ( P <0.001) numerically. There was a dose-response relationship with a significant CO increase of 0.3 L/min already at plasma-3-OHB levels of 0.7 mM ( P <0.001). 3-OHB increased MVO 2 without altering MEE. The response to 3-OHB infusion in terms of MEE and CO did not differ between HFrEF patents and age-matched volunteers. Conclusions: 3-OHB has beneficial hemodynamic effects in HFrEF patients without impairing MEE. These beneficial effects are detectable in the physiological concentration range of circulating 3-OHB levels. The hemodynamic effects of 3-OHB were observed in both HFrEF patients and age-matched volunteers. 3-OHB may potentially constitute a novel treatment principle in HFrEF patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
Sherwood, L. M., Parris, E. E., & Cahill, G. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197003192821209 · Cited by 1,261
Physiological roles of ketone bodies as substrates and signals in mammalian tissues.
Robinson, A. M., & Williamson, D. H. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.1.143 · Cited by 1,012
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ferrannini, E., Mark, M., & Mayoux, E. (2016) · Diabetes Care · doi:10.2337/dc16-0330 · Cited by 975
Regulation of coronary blood flow during exercise
Duncker, D. J., & Bache, R. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00045.2006 · Cited by 936
Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61171-x · Cited by 789
Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., Mari, A., Pieber, T. R., & Muscelli, E. (2016) · Diabetes · doi:10.2337/db15-1356 · Cited by 712
The Failing Heart Relies on Ketone Bodies as a Fuel
Aubert, G., Martin, O. J., Horton, J. L., Lai, L., Vega, R. B., Leone, T. C., Koves, T., Gardell, S. J., Krüger, M., Hoppel, C. L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017355 · Cited by 707
Bedi, K. C., Snyder, N. W., Brandimarto, J., Aziz, M., Mesaros, C., Worth, A. J., Wang, L. L., Javaheri, A., Blair, I. A., Margulies, K. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017545 · Cited by 650
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes
Cox, P. J., Kirk, T., Ashmore, T., Willerton, K., Evans, R., Smith, A., Murray, A. J., Stubbs, B., West, J., McLure, S. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.010 · Cited by 530 · cited 1×
“In highly trained endurance athletes, ingestion of a ketone ester modestly increases exercise capacity.(43) D ow nladed from http://journals.”
BackgroundUtilization of energy-providing substrates in the isolated working rat heart
Taegtmeyer, H., Hems, R., & Krebs, H. A. (1980) · Biochemical Journal · doi:10.1042/bj1860701 · Cited by 467
Insulin, ketone bodies, and mitochondrial energy transduction
Sato, K., Kashiwaya, Y., Keon, C. A., Tsuchiya, N., King, M. T., Radda, G. K., Chance, B., Clarke, K., & Veech, R. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768357 · Cited by 454
Ketone body metabolism and cardiovascular disease
Cotter, D. G., Schugar, R. C., & Crawford, P. A. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00646.2012 · Cited by 440
Control of maximum rates of glycolysis in rat cardiac muscle.
Kobayashi, K., & Neely, J. R. (1979) · Circulation Research · doi:10.1161/01.res.44.2.166 · Cited by 313
Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., & McMurray, J. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3956-x · Cited by 309
Control of glucose utilization in working perfused rat heart.
Kashiwaya, Y., Sato, K., Tsuchiya, N., Thomas, S., Fell, D. A., Veech, R. L., & Passonneau, J. V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47278-x · Cited by 305
Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening K ATP Channels
Ma, W., Berg, J., & Yellen, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0132-07.2007 · Cited by 294
Blood ketone bodies in congestive heart failure
Lommi, J., Kupari, M., Koskinen, P., Näveri, H., Leinonen, H., Pulkki, K., & Härkönen, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00214-8 · Cited by 234
Gormsen, L. C., Svart, M., Thomsen, H. H., Søndergaard, E., Vendelbo, M. H., Christensen, N., Tolbod, L. P., Harms, H. J., Nielsen, R., Wiggers, H., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005066 · Cited by 234
Self-citationMarinho, N. V. S., Keogh, B. E., Costa, D. C., Lammerstma, A. A., Ell, P. J., & Camici, P. G. (1996) · Circulation · doi:10.1161/01.cir.93.4.737 · Cited by 212
Berger, M., Hagg, S. A., Goodman, M. N., & Ruderman, N. B. (1976) · Biochemical Journal · doi:10.1042/bj1580191 · Cited by 192
Schugar, R. C., Moll, A. R., André d’Avignon, D., Weinheimer, C. J., Kovacs, A., & Crawford, P. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.07.010 · Cited by 186
Harms, H. J., Knaapen, P., de Haan, S., Halbmeijer, R., Lammertsma, A. A., & Lubberink, M. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1730-3 · Cited by 167
Self-citationButler, J., Hamo, C. E., Filippatos, G., Pocock, S. J., Bernstein, R. A., Brueckmann, M., Cheung, A. K., George, J. T., Green, J. B., Januzzi, J. L., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.933 · Cited by 164
Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia
Hasselbalch, S. G., Madsen, P. L., Pinborg, L. H., Olsen, K. S., Justesen, N. D., Holm, S., & Paulson, O. B. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.5.e746 · Cited by 155
Evolving Concepts of Myocardial Energy Metabolism: More Than Just Fats and Carbohydrates
Lopaschuk, G. D., & Ussher, J. R. (2016) · Circulation Research · doi:10.1161/circresaha.116.310078 · Cited by 139
Nalos, M., Leverve, X. M., Huang, S. J., Weisbrodt, L., Parkin, R., Seppelt, I., Ting, I., & McLean, A. S. (2014) · Critical Care · doi:10.1186/cc13793 · Cited by 132
Beanlands, R. S., Bach, D. S., Raylman, R. R., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90548-f · Cited by 123
Jeffrey, F. M. H., Diczku, V., Sherry, A. D., & Malloy, C. R. (1995) · Basic Research in Cardiology · doi:10.1007/bf00788500 · Cited by 114
Tuunanen, H., Engblom, E., Naum, A. S., Scheinin, M., Någren, K., Airaksinen, J. K. E., Nuutila, P., Iozzo, P., Ukkonen, H., & Knuuti, J. M. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.06.005 · Cited by 104
Kinetics of ketone body metabolism in fasting humans
Balasse, E. O. (1979) · Metabolism · doi:10.1016/0026-0495(79)90166-5 · Cited by 103
Nørrelund, H., Wiggers, H., Halbirk, M., Frystyk, J., Flyvbjerg, A., Bøtker, H. E., Schmitz, O., Jørgensen, J. O. L., Christiansen, J. S., & Møller, N. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01663.x · Cited by 80
Self-citationKetones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?
Kolwicz, S. C., Airhart, S. E., & Tian, R. (2016) · Circulation · doi:10.1161/circulationaha.116.021230 · Cited by 67
Kim, I. L. S., Izawa, H., Sobue, T., Ishihara, H., Somura, F., Nishizawa, T., Nagata, K., Iwase, M., & Yokota, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01775-8 · Cited by 65
Mäki, M. T., Haaparanta‐Solin, M., Nuutila, P., Oikonen, V., Luotolahti, M., Eskola, O., & Knuuti, J. M. (1998) · PubMed · Cited by 64
Failing Heart and Starving Brain: Ketone Bodies to the Rescue
Taegtmeyer, H. (2016) · Circulation · doi:10.1161/circulationaha.116.022141 · Cited by 44
Fioretto, P., Trevisan, R., Velussi, M., Cernigoi, A. M., Riva, C. D., BRESSAN, M., Doria, A., PAULETTO, N., Angeli, P., DONÁ, C. D., et al. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-2-331 · Cited by 38
Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects
Gadegbeku, C. A. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03196-5 · Cited by 27
Nielsen, R. R., Nørrelund, H., Kampmann, U., Kim, W. Y., Ringgaard, S., Schär, M., Møller, N., Bøtker, H. E., & Wiggers, H. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000187 · Cited by 24
Self-citationKroon, M., Groeneveld, A. B. J., & Smulders, Y. M. (2005) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-005-6865-y · Cited by 21
Hansson, N. H., Tolbod, L. P., Harms, H. J., Wiggers, H., Kim, W. Y., Hansen, E. S. S., Zaremba, T., Frøkiær, J., Jakobsen, S., & Sørensen, J. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-015-0331-0 · Cited by 21
Self-citation
Cited by
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
Lopaschuk, G. D., & Verma, S. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.02.004 · Cited by 894
Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M., & Bauersachs, J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac223 · Cited by 606
Comprehensive quantification of fuel use by the failing and nonfailing human heart
Murashige, D., Jang, C., Neinast, M., Edwards, J. J., Cowan, A., Hyman, M. C., Rabinowitz, J. D., Frankel, D. S., & Arany, Z. (2020) · Science · doi:10.1126/science.abc8861 · Cited by 580
Santos-Gallego, C. G., Vargas-Delgado, A. P., Requena-Ibanez, J. A., Garcia-Ropero, A., Mancini, D., Pinney, S., Macaluso, F., Sartori, S., Roque, M., Sabatel-Perez, F., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.008 · Cited by 531
Metadata
- Authors
- Nielsen, R., Møller, N., Gormsen, L. C., Tolbod, L. P., Hansson, N. H., Sorensen, J., Harms, H. J., Frøkiær, J., Eiskjaer, H., Jespersen, N. R., Mellemkjaer, S., Lassen, T. R., Pryds, K., Bøtker, H. E., & Wiggers, H.
- Venue
- Circulation
- Published
- 2019-04-30
- Volume
- 139
- Issue
- 18
- Pages
- 2129-2141
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2925036255
- Cited by
- 518
- References
- 43
- FWCI
- 33.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.